In this MEDtalk, Geoffrey Dusheiko, Kings College Hospital, and University College London, presents a new anti-viral drug class that may act as a new proxy for treatment and better classification of HBV patients. He also discussed the latest approaches to treating and managing HBV in this MEDtalk.
If you are a doctor, nurse, pharmacist or other healthcare professional with the right to prescribe medicine, you can:
Already a member?
Log in
| Cookie | Duration | Description |
|---|---|---|
| _ga | 2 years | This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors. |
| _gid | 1 day | This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form. |
| Cookie | Duration | Description |
|---|---|---|
| _gat_UA-43794127-5 | 1 minute | This is a pattern type cookie set by Google Analytics, where the pattern element on the name contains the unique identity number of the account or website it relates to. It appears to be a variation of the _gat cookie which is used to limit the amount of data recorded by Google on high traffic volume websites. |
